Prior Authorization Drug Attachment for Lipotropics, Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors

Assigned Number Titlesort descending Version Date Publication Type Other Location Language
F-02505 Effective for use on and after 07/01/2019: Prior Authorization Drug Attachment for Lipotropics, Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors July 1, 2019
Word
English
F-02505 Effective for use on and after 07/01/2019: Prior Authorization Drug Attachment for Lipotropics, Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors July 1, 2019
PDF
English
F-02505 Effective for use on and after 07/01/2019: Prior Authorization Drug Attachment for Lipotropics, Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Instructions July 1, 2019
PDF
English
Last Revised: July 23, 2019